Press Releases 2012

Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY™ Pacing Leads - Dec 17, 2012

The first patient has been implanted with the Boston Scientific Corporation (NYSE: BSX) next generation INGEVITY™ pacing leads in a clinical trial designed to establish the safety...

Read more

Boston Scientific Defibrillators Receive CE Mark for Extended Longevity - Nov 20, 2012

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for increased longevity projections for the INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN®...

Read more

Boston Scientific to Acquire Rhythmia Medical, Inc. - Oct 08, 2012

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation...

Read more

Boston Scientific Receives FDA Approval of First-in-Class S-ICD™ System for Patients at Risk of Sudden Cardiac Arrest -Aug 28, 2012

The U.S. Food and Drug Administration has granted Boston Scientific Corporation (NYSE: BSX) regulatory approval for its S-ICD™ System, the world's first and only commercially available...

Read more

Boston Scientific Launches New Implantable Defibrillation Lead In Europe And Asia - Aug 24, 2012

Boston Scientific Corporation (NYSE: BSX) has received regulatory approval to market the RELIANCE® 4-FRONT™ lead, its next generation implantable defibrillation lead now available...

Read more

Boston Scientific INGENIO Family of Pacemakers Receives CE Mark Approval for use in MRI Scans - Jul 27, 2012

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for use of its INGENIO™ and ADVANTIO™ pacemakers in patients in need of a magnetic resonance imaging (MRI) scan...

Read more

Boston Scientific S-ICD™ System Named Most Innovative Product at Cardiostim 2012 - Jul 02, 2012

Attendees of Cardiostim 2012, a global medical conference held recently in Nice, France, have selected the S-ICD™ System recently acquired by Boston Scientific Corporation...

Read more

Boston Scientific Announces First Patient Active with LATITUDE™ NXT Remote Patient Management System - Jun 14, 2012

Dr. Roberto Verlato, head of cardiology at Camposampiero Hospital in Verona, Italy initiated use of the LATITUDE NXT system with a patient implanted with an INGENIO™ SR...

Read more

Boston Scientific Closes Cameron Health Acquisition - Jun 08, 2012

Boston Scientific Corporation (NYSE: BSX) has closed its acquisition of Cameron Health, Inc. of San Clemente, California, and, as a result, added to its product portfolio the world's first...

Read more

Boston Scientific Announces Launch of INGENIO™ Family of Pacemakers in Europe - Apr 10, 2012

Boston Scientific Corporation (NYSE: BSX) announces CE Mark approval and European market launch of its INGENIO™ and ADVANTIO™ pacemakers and INVIVE™ cardiac...

Read more

Boston Scientific to Acquire Cameron Health, Inc. - Mar 08, 2012

Boston Scientific Corporation (NYSE: BSX) announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San Clemente, California. Cameron...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com

Company Profile
Top